The patients’ perspective at the ESHRE Annual Meeting
The European Society for Human Reproduction and Embryology (ESHRE) has generously given Fertility Europe time in the main program of their Annual Meeting. This ‘Patient Session’ consists of three or four lectures focusing on the patient’s perspective of a particular subject.
Ana Galhardo (Portugal): ‘Surrogacy in Portugal – from struggle to accomplishment’
Kaisa Kivipuro (Finland): ‘What it is to be a wombless woman in the age of ART’s? Patient’s perspective on gestational surrogacy in Finland’.
***
Geneva 2017
Pushing things forward: accelerating change – patient association role in MAR
(4 July 2017, 14.00-15.00)
Satu Rautakallio-Hokkanen (Finland), Chair of Fertility Europe Executive Committee: ’25 million people matter. Patients network as a driving force in Europe.’ ‘When you are diagnosed with infertility you are at your weakest when you have to be at your strongest.’
Jose Knijnenburg (The Netherlands) from Freya: ‘Questions? Questions! How can patients contribute to the improvement of fertility care?’ By teaching and encouraging patients to ask questions to empower them. And by Freya asking questions: to patients about what they need and have experienced, and to caregivers about the clinics’ practice.’
Irina Popova (Bulgaria)from Zachatie Sdrujenie: ‘Reproductive health education of adolescent as a tool for early prevention of infertility.’
Irena Lodder Rozic (Croatia) from RODA – Roditelji u akciji: ‘MAR in Croatia: Retrospective and Prospective. The role of patients’ organisation in positive change of MAR practices.’
Diana Guerra Diaz (Spain): ‘Psychosocial differences between medical and social infertility.’
Ana Galhardo (Portugal): ‘Are there other choices? Attitudes towards social freezing, gamete donation and surrogacy in young adults in reproductive age.’
Karoline Steckley: ‘Missing the Fertility Train? Italian lifestyle, social structure, economy and how the country that loves kids is making it difficult to have them.’
Irina Popova (Bulgaria): ‘The late lessons of delayed motherhood – from a patient’s perspective.’
***
Munich 2014
Social infertility (e.g. gamete freezing for social reasons; delayed pregnancy; age factor)
Rita Vassena (Spain): ‘Social egg freezing- the clinician point of view: information, indications and expectations.’
Vanya Savova (Bulgaria): ‘The Conflict between Psychology and Medicine – Social Freezing Motivation and Consequences.’
Hana Konečná (Czech Republic): ‘Social freezing, unlimited access and open identity – a Rainmaker?’
Fernando Oliveira (Portugal): ‘Medicalizing and socializing infertility in the 21st century.’
***
London 2013
Managing relationships through infertility
Sheila Pike (UK): ‘Decision-making, ending treatment and the couple relationship: a counsellor’s perspective.’
Helga Sol (Iceland): ‘Love, sex and infertility. The art of growing as a couple when dealing with infertility.’
Erikjan Bor (The Netherlands): ‘Surviving Infertility: How I never became a dad, but still going strong with my wife.’
Tim Child (UK): ‘Ending fertility treatment- when, why and how should clinicians advise our patients?’
***
Istanbul 2012
Quality in various aspects of fertility treatment (quality of medical care, quality of clinics, quality of information, quality of life)
Willianne Nelen (The Netherlands): ‘The role of clinical guidelines in quality of care.’
Alina Beatris David (Romania): ‘Quality in MAR perceived by the Eastern European Patient.’
Elin Einarsdottir (Iceland): ‘Quality of Treatment, when there is only ONE.’
Peter Thompson (UK): ‘Quality from the Regulator’s perspective’
***
Stockholm 2011
Education in fertility awareness. From prevention to action: whose duty?
Hana Konečná (Czech Republic): ‘Reproductive medicine: good servant but bad boss?
Tanja Tydén (Sweden): ‘Attitudes to and awareness of fertility issues among adolescents and young adults in Sweden.’
Geertrui de Cock (Belgium): ‘Infertility prevention campaign: a multi-stakeholder example from Flanders, Belgium’
***
Rome 2010
How patient-friendly is patient-friendly? A global overview.
Guido Pennings (Belgium):’The ethical approach to patient friendly AR’
Vincenza Zambaldi (Italy): ‘Patient-friendliness in Italy – which will represent the Western-European perspective’
Denisa Priadková (Slovak Republic): ‘How patient-friendly in Eastern European countries is translated into a quick way to IVF, with a lack of information about choices etc.’
Gamal Serour (Egypt): ‘What does patient-friendly mean in the developing countries?’
***
Amsterdam 2009
José Knijnenburg (The Netherlands): ‘Broad collaboration for new guidelines in the Netherlands; The role of the patients.’
Join our newsletter to receive heartfelt stories, expert insights, and updates from Fertility Europe.
Be the first to know about our advocacy efforts and community events
Discover ways your support makes an impact
Hear directly from those whose lives you’re changin
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
